^
    No biomarker
    Osteosarcoma
    doxorubicin hydrochloride
    Sensitive
    :
    A1
    No biomarker
    Osteosarcoma
    ADX-2191
    Sensitive
    :
    A1
    No biomarker
    Osteosarcoma
    regorafenib
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    IE
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    gemcitabine + docetaxel + cyclophosphamide
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    carboplatin + cyclophosphamide + etoposide IV
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    carboplatin + cyclophosphamide
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    cyclophosphamide + etoposide IV
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    gemcitabine + docetaxel + ifosfamide
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    carboplatin + ifosfamide + etoposide IV
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    carboplatin + ifosfamide
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    cisplatin + ifosfamide + methotrexate + SGN-15
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    cisplatin + ifosfamide + pegylated liposomal doxorubicin
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    ifosfamide + etoposide oral + methotrexate
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    sorafenib + everolimus
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    gemcitabine
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    gemcitabine + docetaxel
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    cyclophosphamide + topotecan
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    cabozantinib tablet
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    sorafenib
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    ifosfamide
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    cisplatin + SGN-15 + methotrexate IV
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    cisplatin + SGN-15
    Sensitive
    :
    A2
    TMB-H
    Osteosarcoma
    pembrolizumab
    Sensitive
    :
    A2
    MSI-H/dMMR
    Osteosarcoma
    pembrolizumab
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    MAP
    Sensitive
    :
    A2
    No biomarker
    Osteosarcoma
    methotrexate
    Sensitive
    :
    A2
    NTRK2 fusion
    Osteosarcoma
    larotrectinib
    Sensitive
    :
    C1
    NTRK1 fusion
    Osteosarcoma
    larotrectinib
    Sensitive
    :
    C1
    NTRK3 fusion
    Osteosarcoma
    larotrectinib
    Sensitive
    :
    C1
    CDK4 overexpression
    Osteosarcoma
    palbociclib
    Sensitive
    :
    C2
    ERCC1 K504Q
    Osteosarcoma
    cisplatin
    Resistant
    :
    C3